Precision Biomarker Laboratories (PBL) is a unique commercial CRO, wholly owned by Cedars-Sinai. We provide complete proteomics solutions from unbiased discovery to targeted biomarker development. Our platforms include discovery and targeted mass spectrometry, SEER Proteograph, and immunoassay technologies such as Olink, Quanterix, and Meso Scale Discovery (MSD). Jenny Van Eyk, a founder and director at PBL, is a global leader in applied proteomics research. Our clients benefit greatly from our close association with her world renowned Advanced Clinical Biosystems Research Institute (ACBRI). PBL is constantly optimizing workflows with innovations from ACBRI.
Additional instrumentation in our GLP compliant/CLIA labs include Thermo's extraordinary Astral, Sciex triple quads, Bruker timsTOF, Thermo Orbitraps, Seer Proteograph Suite sample prep, and automation with i7’s and Evosep.